Status: current, Defined. Date: 30-Apr 2019. Module: Australian Medicines Terminology module
Descriptions:
Id | Description | Lang | Type | Status | Case? | Module |
3280261000168115 | Vipdomet 12.5/500 (alogliptin 12.5 mg + metformin hydrochloride 500 mg) tablet (trade product unit of use) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
3280271000168114 | Vipdomet 12.5/500 tablet | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
Vipdomet 12.5/500 tablet | Is a | Vipdomet 12.5/500 | true | Inferred relationship | Some | ||
Vipdomet 12.5/500 tablet | Is a | alogliptin 12.5 mg + metformin hydrochloride 500 mg tablet | true | Inferred relationship | Some | ||
Vipdomet 12.5/500 tablet | Is a | trade product unit of use | true | Inferred relationship | Some | ||
Vipdomet 12.5/500 tablet | has manufactured dose form | tablet | true | Inferred relationship | Some | ||
Vipdomet 12.5/500 tablet | has unit of use | tablet | true | Inferred relationship | Some | 1949868073 | |
Vipdomet 12.5/500 tablet | has intended active ingredient | metformin | true | Inferred relationship | Some | 1949868072 | |
Vipdomet 12.5/500 tablet | has Australian BoSS | metformin hydrochloride | true | Inferred relationship | Some | 1949868072 | |
Vipdomet 12.5/500 tablet | has Australian BoSS | alogliptin | true | Inferred relationship | Some | 313977372 | |
Vipdomet 12.5/500 tablet | has intended active ingredient | alogliptin | true | Inferred relationship | Some | 313977372 |
Reference Sets
Trade product unit of use reference set